Valbenazine

🧮 Dose calculator

Tardive dyskinesia · Regimen source: FDA Ingrezza · 2.1

• • 40 or 60 mg may be considered depending on response and tolerability. FDA Ingrezza · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ingrezza · 8.1

  “Risk Summary The limited available data on INGREZZA or INGREZZA SPRINKLE use in pregnant women are insufficient to inform a drug-associated risk.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Ingrezza · 8.2

  “Risk Summary There is no information regarding the presence of valbenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ingrezza · 8.4

  “Safety and effectiveness of INGREZZA and INGREZZA SPRINKLE have not been established in pediatric patients.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Ingrezza · 8.5

  “No dose adjustment of INGREZZA or INGREZZA SPRINKLE is required for elderly patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.